EARLY CANCER INTERVENTION - FROM LABORATORY DISCOVERIES TO THE COMMUNITY
The NUS Centre for Cancer Research (N2CR) proudly presents Singapore’s inaugural symposium for early cancer intervention research, ‘Early Cancer Intervention: From Laboratory Discoveries to the Community’, which will take place on 13th and 14th May 2024 at the Centre for Translational Medicine (MD6), National University of Singapore.
As the demand for effective cancer prevention and early detection strategies continues to rise in Singapore, N2CR is committed to strengthening the local and regional cancer research community through facilitation and nucleation of research ideas on early cancer intervention research.
We warmly invite you to our upcoming symposium. We will showcase the growing field of early cancer intervention in Asia and will serve as a vital platform for scientists and clinicians to converge and explore the latest advancements in early cancer intervention strategies, spanning from cutting-edge research to community-centric strategies.
This symposium will focus on the following key themes :
- Early Carcinogenesis Research
- Advancements in Early Diagnosis and Intervention Technologies
- Community-Centric Screening Strategies
GUEST OF HONOUR
TAN Chorh Chuan
Permanent Secretary (National Research and Development)
Permanent Secretary (Public Sector Science and Technology Policy and Plans Office), Prime Minister’s Office
Chairman, Agency for Science, Technology and Research
OUR SPEAKERS
KEYNOTE SPEAKERS
Nitzan ROSENFELD
Director, Barts Cancer Institute,
Queen Mary University of London
Joseph SUNG
Senior Vice President (Health & Life Sciences),
Nanyang Technological University, Singapore
YEOH Khay Guan
Senior Vice President (Health Affairs),
National University of Singapore
SPEAKERS
Pierce CHOW
National Cancer Centre Singapore
Jeffrey HALTER
University of Michigan
George HANNA
Imperial College London
Mikael HARTMAN
National University Hospital, Singapore
LI Jingmei
Genome Institute of Singapore, A*Star
LIM Chwee Teck
Robert SCHARPF
Johns Hopkins Bloomberg School of Public Health
SHAO Hui Lin
TAM Wai Leong
TAN Bee Huat Iain
TAN Ker Kan
Cristian TOMASETTI
TOO Heng-Phon
Ashok VENKITARAMAN
TAN Ker Kan
Cristian TOMASETTI
PROGRAMME
Day 1
Day 2
CALL FOR ABSTRACTS - CLOSED
We invite you to submit your abstracts on the theme of Early Cancer Intervention, to be considered for inclusion in this symposium.
Please submit your abstract as an attachment in PDF format. Abstracts are limited to a maximum of 250 words excluding authors’ affiliation.
Authors’ affiliations should be submitted in the following sample format:
Peter Tan1,2
1NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore 2Department of Medicine, National University of Singapore
Please refer to the Abstract Template provided.
Click here to submit your abstract by 1 April 2024.
Only authors of shortlisted abstracts will be notified via email (by end April 2024), and invited to present at the ‘Early Cancer Intervention – from Laboratory Discoveries to the Community’ on 13th or 14th May 2024.
Authors selected to present their abstracts orally will be reimbursed for the cost of their symposium ticket.
For any queries please email n2cr@nus.edu.sg
SPONSORS
MEDIA PARTNER
ORGANISERS
Polly CHEN
LEE Soo Chin
Jimmy SO Bok Yan
National University Cancer Institute, Singapore
Ashok VENKITARAMAN
Cancer Science Institute of Singapore
